2.86

12.27% -0.40

After Hours: 2.90 0.04 +1.40%

Hyperion Defi Inc (HYPD)

Overview News Price History Discussions Forecast

Hyperion Defi Inc stock is traded at $2.86, with a volume of 440.31K. It is down -12.27% in the last 24 hours and down -4.35% over the past month. Hyperion DeFi Inc is a USA-based company building a long-term strategic treasury of Hyperliquid's native token, HYPE. The Company is focused on providing its shareholders with simplified access to the Hyperliquid ecosystem, one of the fastest-growing and highest-revenue-generating blockchains in the world. Shareholders benefit from a gradually compounding exposure to HYPE, both from its native staking yield and additional revenues generated from its on-chain utility. It is working to provide its shareholders with simplified exposure to the Hyperliquid ecosystem, which is believed to be among the highest-revenue-generating blockchains in the world, according to information from various blockchain data tracking sources, including Artemis Analytics and DefiLlama.

Previous Close:

$3.26

Open:

$3.21

24h Volume:

440.31K

Relative Volume:

0.77

Market Cap:

$43.35M

Revenue:

$1.04M

Net Income/Loss:

$-32.99M

P/E Ratio:

-0.4169

EPS:

-6.8606

Net Cash Flow:

$-87.95M

1W Performance:

-8.92%

1M Performance:

-4.35%

6M Performance:

-19.66%

1Y Performance:

+0.00%

1-Day Range:

$2.85

$3.25

1-Week Range:

$2.85

$3.47

52-Week Range:

$2.491

$16.12

Hyperion Defi Inc Stock (HYPD) Company Profile

Name

Hyperion Defi Inc

Sector

Healthcare (1094)

Industry

Biotechnology (615)

Phone

833-393-6684

Address

295 MADISON AVENUE, NEW YORK

Employee

Twitter

Next Earnings Date

2026-08-12

Latest SEC Filings

HYPD's Discussions on Twitter

Compare HYPD vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HYPD Hyperion Defi Inc	2.86	49.41M	1.04M	-32.99M	-87.95M	-6.8606
VRTX Vertex Pharmaceuticals Inc	522.25	134.41B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	676.23	68.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	919.94	57.01B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	321.59	41.79B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	190.46	40.39B	742.00K	-1.37B	-1.07B	-7.0731

Hyperion Defi Inc Stock (HYPD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-24-25	Initiated	Chardan Capital Markets	Buy
Dec-16-25	Initiated	Cantor Fitzgerald	Overweight
Nov-18-24	Downgrade	H.C. Wainwright	Buy → Neutral
Mar-01-21	Initiated	Northland Capital	Outperform
Feb-03-20	Downgrade	Oppenheimer	Outperform → Perform

Hyperion Defi Inc Stock (HYPD) Latest News

Jul 06, 2026

Enterprise value to revenue forward of Hyperion DeFi, Inc. – NASDAQ:HYPD - TradingView

Jul 06, 2026

Jul 05, 2026

Hyperion DeFi Stockholders Maintain Governance and Board Stability - TipRanks

Jul 05, 2026

Jul 01, 2026

Director Walters Happy David receives 58,917 RSU grant at HYPERION DEFI (HYPD) - Stock Titan

Jul 01, 2026

[Form 4] HYPERION DEFI, INC. Insider Trading Activity - Stock Titan

Jul 01, 2026

HYPERION DEFI (HYPD) director receives 58,917 restricted stock units in equity grant - Stock Titan

Jul 01, 2026

Director Michael S. Geltzeiler awarded 58,917 HYPERION DEFI (HYPD) RSUs - Stock Titan

Jul 01, 2026

Hyperion DeFi (HYPD) investors back directors, reject written consent change - Stock Titan

Jul 01, 2026

HYPD Maintained by Cantor Fitzgerald -- Price Target Raised to $6.60 - GuruFocus

Jul 01, 2026

Forsakringsaktiebolaget Avanza Pension amends stake in Hyperion DeFi (HYPD) - Stock Titan

Jul 01, 2026

Jun 29, 2026

Hyperion DeFi, Inc.(NasdaqCM: HYPD) added to Russell Microcap Value Benchmark Index - marketscreener.com

Jun 29, 2026

Hyperion DeFi, Inc.(NasdaqCM: HYPD) added to Russell 3000E Index - marketscreener.com

Jun 29, 2026

Hyperion DeFi, Inc.(NasdaqCM: HYPD) added to Russell Microcap Index - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Hyperion DeFi, Inc.(NasdaqCM: HYPD) added to Russell 3000E Value Benchmark - marketscreener.com

Jun 28, 2026